Back to Authors

Yoshino, Takayuki

A5030680733 | I4210145079

Mayo Clinic

National Cancer Center Hospital East

Citations 1

MOUNTAINEER-03 phase III study design: first-line mFOLFOX6 + tucatinib + trastuzumab for HER2+ metastatic colorectal cancer

Future Oncology | December 26, 2024 | Volume: 21 | Issue: 3 | Pages: 303-311

10.1080/14796694.2024.2441101 | PMID 39723627